 | ||||
 | ||||
 | | | | |
Pharmaceutical Marketing
Didi Mack, RxME News
| ||||||||||||||||||||||
Pharmaceutical Marketing | ||||||||||||||||||||||
| ||||||||||||||||||||||
Didi Mack, RxME News | ||||||||||||||||||||||
| | | | | | | | |||||||||||||||
Okay: you're about to launch a new brand, and you're reviewing your launch materials that you'll be sending to DDMAC. RxME.com links you to the information you need. You also get fast links to industry news, including health and science information. RxME is here to help pharmaceutical marketing executives like you. ©2005 RxME.com All rights reserved. | |||||||||||||
 |  |  |  | ||||||||||
 | |||||||||||||
 |  |  | |||||||||||
 |  |  |  | ||||||||||
 |  |  |  | ||||||||||
 |  |  |  | ||||||||||
Here are some important reminders about DDMAC's advertising regulations: * Pre-launch ads can mention your brand's indication or your brand name, but not both. * In journal ads, the size of your brand's generic should be half the size of the logo. * Efficacy and safety data should be presented with equal weight and prominence. * Brief summary and full PI information should appear in type size no less than 6 points. | |||||||||||||
| | | | | | | | | | | | | |
Home | Mission | FDA | Stocks | Jobs | Fun | CMME | Companies | Feedback | Recruiters | Vacations | Interview | | ||
| | |